Address
Mereside
Alderley Park
Alderley Edge
Cheshire SK10 4TG
United Kingdom
Contact
Andrew Wilkinson+4401612749440
Andrew.Wilkinson@infextx.com
Website
Drug discovery organisation
We acquire, develop and license innovative drugs to treat pandemic infections
A differentiated pipeline through in-house drug discovery, acquisition, co-development and in-licensing of early stage/pre-clinical candidates.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- CARB-X
- OTHER / NA
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
N.A.
Drug disovery organisation focussed on developing innovative drugs to treat pandemic infections
A pipeline of programmes targeting bacterial, viral and fungal infections.
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!